|
Case Studies - Pharmaceuticals

Pharmaceutical firms hoping to make critical portfolio, project,
resource and process investment decisions need a reliable analytical
solution to accelerate new product development. Some major pharmaceutical
firms have already invested in predictive technology solutions from
PROMODEL including Pfizer, Johnson & Johnson and Bristol Myers
Squibb.
With the unique software and service offerings from PROMODEL, pharmaceutical
customers can answer:
- Where are the resource constraints on the current portfolio
and how many resources do I need to meet demand?
- What will the cost/benefit impact be for pulling ahead or delaying
a particular project?
- How will process improvement initiatives centering on automation,
electronic data capture, clinical supplies, etc. impact the bottom
line? Which should be done first?
- What will the financial impact be for changing program priorities?
- What will the cost/benefit impact be for "licensing in"
or outsourcing compounds?
- How will a major program decision point impact the portfolio
& resource requirements?
PROMODEL technology has been successfully applied to the following
pharmaceutical applications:
- Accelerating drug discovery processes
- Resource planning and optimization
- Improving new product throughput
- Product portfolio management
- Staff planning and optimization
- Manufacturing and logistics improvement
- Business reengineering
- Evaluating new equipment and processes
|

|
Case Studies Menu
- Automotive
- Aerospace
- Chemicals
- Engineering
- Food / Drink
- Oil / Gas
- Logistics
- Pharmaceuticals
- Finance
|